Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection.

Reddy, Abhinav V; Hill, Colin S; Sehgal, Shuchi; Ding, Ding; Hacker-Prietz, Amy; He, Jin; Zheng, Lei; Herman, Joseph M; Meyer, Jeffrey; Narang, Amol K

Reddy, Abhinav V; Hill, Colin S; Sehgal, Shuchi; Ding, Ding; Hacker-Prietz, Amy; He, Jin; Zheng, Lei; Herman, Joseph M; Meyer, Jeffrey; Narang, Amol K.

Afiliação

Reddy AV; Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hill CS; Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sehgal S; Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ding D; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hacker-Prietz A; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
He J; Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zheng L; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Herman JM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Meyer J; Department of Radiation Oncology, Northwell Health Cancer Institute, New Hyde Park, NY, USA.
Narang AK; Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.